Cue Biopharma (CUE) delivered earnings and revenue surprises of +30.00% and -14.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Boost your job search with these 7 smart AI prompts. Learn how ChatGPT can rewrite your résumé, fix gaps, and craft confident ...

Apple Fitness+ has long been an overlooked Apple service, and recent reports show it's struggling to make profits. Here's why ...

Bret: Reminds me of the great Will Rogers line: “I don’t belong to any organized political faith. I am a Democrat.” But maybe ...

Palm Beach parties, property wars and a 'little black book' — the truth about Trump's friendship with Epstein - It’s the ...

Google's 2025 Pixel update brings critical fixes for camera quality, system stability, emergency calling, and battery ...

Quebec Health Minister Christian Dubé is proposing new draft regulations to further reduce physician paperwork and free up 310,000 medical appointments, according to his office.

Well, it's back again, this time in the form of a small update: the Freestyle Edge RGB Plus. When I say small, I really do ...

Google's third generation foldable, officially called the Pixel 10 Pro Fold but colloquially simply the Pixel 10 Fold, shows ...

The iPhone 17 series is one of Apple’s boldest in recent memory. The base iPhone 17 has adopted once Pro-only features, such ...

The US Congress has officially voted to reopen the federal government, providing an immediate positive catalyst for equities that is erasing the market blues of the past week. Read more here ...